To: "Jeffrey E." <[email protected]>
From:
To: "Jeffrey E." <[email protected]>
Subject: Re: From wikipedia...
Date: Mon, 19 Jun 2017 14:46:00 +0000 >
Maybe so
On Jun 19, 2017, at 1:09 AM, jeffrey E. [email protected]> wrote:
Are the ears - Flowers. Wax coating small hairs
On Mon, Jun 19, 2017 at 2:12 AM wrote:
I went through this list of protein aggregation diseases or proteopathies ... or what
I'm calling aggregopathies. It's not a problem with the protein, it's a problem be they
aggregate. Anyway, I just did a basic search of all of the names and checked to see if
there was evidence for change in intracellular PH with all...yup/not all are in neurons.
Weird = this is what happens when you acidify the soil.
Proteopathy Major aggregating protein
Alzheimer's diseaserlq Amyloid [3 peptide (AR); Tau
protein (see tauopathies)
Cerebral [3-amyloid angiopathy 1491 Amyloid [3 peptide (A(3)
Retinal ganglion cell degeneration in glaucoma1501Amyloid [3 peptide (A(3)
Prion diseases (multiple)I511 Prion protein
Parkinson% disease and
other synucleinopathies (multiple)(521a-Synuclein
Tauopathies (multiple)153] Microtubule-associated protein tau (Tau protein)
Frontotemporal lobar degeneration (FTLD) (Ubi+,
Tau-)154I TDP-43
FTLD_FUS1541 Fused in sarcoma (RJS) protein
Amyotrophic lateral sclerosis (ALS)1551561Superoxide dismutase, TDP-43, FUS, C9ORF72,
ubiquilin-2 (UBQLN2)
Huntington's disease and other trinucleotide repeat
disorders (multiple)15115e1 Proteins with tandem glutamine expansions
Familial British dementia[491 ABri
Familial Danish dementia[491 ADan
Hereditary cerebral
hemorrhage with amyloidosis (Icelandic) (HCHWA-I) 1491Cystatin C
CADASIL1591 Notch3
Alexander diseaserq Glial fibrillary acidic protein (GFAP)
Seipinopathiespii Seipin
EFTA00697382
Familial amyloidotic neuropathy, Senile
systemic amyloidosis 2 Transthyrefin 16 1
Serpinopathies (multiple)1631 Serpins
AL (light chain) amyloidosis (primary systemic
amyloidosis ) Monoclonal immunoglobulin light chains1621
All (heavy chain) amyloidosis Immunoglobulin heavy chains[621
AA (secondary) amyloidosis Amyloid A protein[621
Type II diabetes[641 Islet amyloid polypeptide (IAPP; amylin)
Aortic medial amyloidosis Medin (lactadherin) 16~1
ApoAl amyloidosis Apolipoprotein Alt6~1
ApoAll amyloidosis Apolipoprotein Allt6~1
ApoAlV amyloidosis Apolipoprotein AIV1621
Familial amyloidosis of the Finnish type (FAF) Gelsolin[621
Lysozyme amyloidosis Lysozymet 6~1
Fibrinogen amyloidosis Fibrinogen 1621
Dialysis amyloidosis Beta-2 microglobulint 6~1
Inclusion body myositis/myopathy [69 Amyloid f3 peptide (AB)
Cataractsi sq Crystallins
Retinitis pigmentosa with rhodopsin mutations [671 rhodopsin
Medullary thyroid carcinoma Calcitonin (621
Cardiac atrial amyloidosis Atrial natriuretic factort6~1
Pituitary prolactinoma Prolactint6~1
Hereditary lattice comeal dystrophy Keratoepithelin (621
Cutaneous lichen amyloidosis (681 Keratins
Mallory bodies(691 Keratin intermediate filament proteins
Corneal lactoferrin amyloidosis Lactoferrint 6~1
Pulmonary alveolar proteinosis Surfactant protein C (SP-C)t6~1
Odontogenic (Pindborg) tumor amyloid Odontogenic ameloblast-associated protein16~1
Seminal vesicle amyloid Semenogelin 1164
Apolipoprotein C2 amyloidosis Apolipoprotein C2 (ApoC2)1621
Apolipoprotein C3 amyloidosis Apolipoprotein C3 (ApoC3)1621
Lect2 amyloidosis Leukocyte chemotactic factor-2 (Lect2)t6~1
Insulin amyloidosis Insulin(621
Galectin-7 amyloidosis (primary localized cutaneous
amyloidosis) Galectin-7 (Gal7)(621
Corneodesmosin amyloidosis Corneodesmosinl 6~1
Enfuvirtide amyloidosisr mi Enfuvirtidel 6~1
Cystic Fibrosis cystic fibrosis transmembrane conductance
regulator (CFTR) protein
Sickle cell diseaserni Hemoglobin
please note
EFTA00697383
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00697384